METHOD OF SUPPRESSING TUMOUR GROWTH Russian patent published in 2014 - IPC A61K38/08 A61K38/12 A61K38/19 

Abstract RU 2530592 C2

FIELD: medicine.

SUBSTANCE: invention relates to biology and medicine and is aimed at the increase of efficiency of the tumour growth suppression with the application of recombinant human proteins, which bind with a receptor of cytokine TRAIL/Apo2L and trigger apoptotic death of tumour cells, without damaging normal cells. In particular the invention relates to a method of suppressing the tumour growth. The invention consists in the fact that the said recombinant proteins, binding with receptors of cytokine TRAIL/Apo2L, are applied in a combination with substances, which suppress resistance of the tumour cells to TRAIL proteins, and in addition to it cyclic peptide Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys is applied. It is supposed that the said peptide enhances the penetration of TRAIL from the vessels to the tumour cells.

EFFECT: application of a combination of recombinant TRAIL proteins and substances, which increase the sensitivity of the tumour cells to them, in a combination with the said peptide in accordance with the claimed invention, makes it possible to increase efficiency of the tumour growth suppression.

3 dwg, 3 ex

Similar patents RU2530592C2

Title Year Author Number
CSF1R-BASED CHIMERIC PROTEINS 2018
  • Schreiber Taylor
  • Fromm George
  • De Silva Suresh
RU2792239C2
TARGETED TGF BETA INHIBITION 2015
  • Lo Kin-Min
RU2752424C2
ANTI-DR5 ANTIBODY AND USE THEREOF 2018
  • Doh Hyounmie
  • Lee Dongsop
  • Lee Hanyoung
  • Kim Yoojin
  • Han Kyungmi
  • Jung Eunee
  • Kim Donghyeon
  • Song Dongsup
  • Shin Kum-Joo
  • Woo Soyon
RU2735956C1
HUMANIZED ANTIBODY AGAINST PD-1 AND ITS USE 2019
  • Shie Lianzy
  • San Chanyun
  • Ma Chuen
RU2803460C2
NEW ANTIBODIES AND NUCLEOTIDE SEQUENCES AND THEIR USE 2019
  • Frendeus, Bern
  • Tejge, Ingrid
  • Zemrikh, Monika
  • Mortensson, Linda
  • Kholmkvist, Petra
  • Marshan, Zhan-Batist
  • Silvestr, Natali
RU2802450C2
AMHRII BINDING COMPOUNDS FOR THE PREVENTION OR TREATMENT OF LUNG CANCERS 2018
  • Barret Jean-Marc
  • Prost Jean-Francois
  • Lahmar Mehdi
  • Degove Stephane
  • Dubreuil Olivier
  • Nicolas Andre
  • Meseure Didier
RU2797506C2
PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE INGREDIENT A FUSED PROTEIN IN WHICH A TUMOR-PENETRATING PEPTIDE AND AN ANTIANGIOGENIC AGENT ARE FUSED FOR PREVENTING AND TREATING CANCER OR ANGIOGENESIS-RELATED DISEASES 2016
  • Kvon, Khiuk-Sang
  • Ko, Dzong-Khi
  • Li, Jong-Min
  • Dzung, Khiej-Joon
  • Yang, Seok-Voo
  • Kang, Dzae-Khoon
  • Kim, Jong-Sung
RU2727238C2
MESOTHELINIC CAR RECEPTORS AND USE THEREOF 2020
  • Adusumilli, Prasad, S.
  • Sadelain, Michel
RU2822193C2
POLYVALENT BINDING PROTEINS FOR ACTIVATION OF NATURAL KILLER CELLS AND THEIR THERAPEUTIC APPLICATION FOR TREATMENT OF MALIGNANT NEOPLASM 2018
  • Chang, Gregory, P.
  • Cheung, Ann, F.
  • Haney, William
  • Grinberg, Asya
RU2809125C2
BISPECIFIC ANTIGEN-BINDING PROTEIN EGFR/CD16 2019
  • Kluge Michael
  • Tesar Michael
  • Fucek Ivica
  • Ellwanger Kristina
  • Reusch Uwe
  • Damrat Michael
  • Rajkovic Erich
  • Treder Martin
RU2792240C2

RU 2 530 592 C2

Authors

Akatov Vladimir Semenovich

Chekanov Aleksej Vladimirovich

Fadeev Roman Sergeevich

Bezborodova Ol'Ga Alekseevna

Nemtsova Elena Romanovna

Jakubovskaja Raisa Ivanovna

Dates

2014-10-10Published

2012-07-20Filed